Sharikas hired to attract Life Science companies to Greater Richmond

The Greater Richmond Partnership (“GRP”) has hired Kiryako Sharikas to join the team as Business Development Manager – Life Sciences. Sharikas will focus on targeting life science and pharmaceutical companies interested in expanding to the Richmond Region.

“Kiryako’s experience in marketing will translate well as he markets the region as the #1 mid-sized location in the U.S. for life science companies to invest,” said Jennifer Wakefield, President + CEO of the Greater Richmond Partnership. “With Kiryako on the team, GRP will now have a dedicated point of contact to expand the shared effort to make our region the capital of advanced pharmaceutical manufacturing.”

Sharikas has more than eight years of experience in digital marketing for employers including CoStar Group, Sheltering Arms, Compare.com and NetSearch. Sharikas’ experience will be a major asset as he transitions to the new role. Sharikas is a graduate of Virginia Commonwealth University and Reynolds Community College.

ATCC Receives New CDC Award to Advance Influenza Testing and Surveillance

ATCC has been selected by the Centers for Disease Control and Prevention (CDC) for a new contract to support serological assays for the detection and characterization of influenza viruses. The award, valued at up to $7.3 million over the 5-year contract period (contract 75D30126C21030), will support CDC’s National Center for Immunization and Respiratory Diseases, Influenza …

08/18/2026

Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

Nanochon, a medical device company developing Chondrograft™, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá’s Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá. The study will evaluate the safety and performance of Chondrograft™ in patients …

08/14/2026

Transforming the finance function in life sciences: Empower scalable growth

Life sciences companies operate in one of the most complex business environments. Long R&D timelines, limited early-stage revenue, and dependence on external funding create a financial landscape where every decision carries strategic weight. In this context, finance is not a back-office function. It is an operational engine that drives whether a company survives, scales, or …

News